Xeris Biopharma Holdings (XERS) Return on Invested Capital [ROIC] (2022 - 2025)
Xeris Biopharma Holdings (XERS) posted Return on Invested Capital [ROIC] of -4.52% for Q2 2025, up 12.71 percentage points from -17.23% a year earlier and up 6.20 percentage points from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Return on Invested Capital [ROIC] (2022 - 2025) Analysis & Trends
For FY2024, Xeris Biopharma Holdings' Return on Invested Capital [ROIC] came in at -16.71%, up 4.01 percentage points from FY2023.
- In prior years, Xeris Biopharma Holdings' Return on Invested Capital [ROIC] was -20.72% in FY2023 (+18.13 pp) and -38.85% in FY2022.
- The Q2 2025 figure stands as the highest quarterly Return on Invested Capital [ROIC] in data going back to Q1 2022.
- On a year-over-year basis, Return on Invested Capital [ROIC] has increased in each of the last ten quarters, with an average year-over-year change of +12.40 percentage points over the last eight quarters.
- The year-over-year gain in Return on Invested Capital [ROIC] has ranged between 2.61 percentage points (Q3 2024) and 31.89 percentage points (Q3 2023) over the last five years.
- According to Business Quant data, Return on Invested Capital [ROIC] for the three prior quarters was -10.71% (Q1 2025), -16.55% (Q4 2024) and -21.77% (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 30.89% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.57% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 24.28% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.52% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 23.11% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 15.60% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.11% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 12.34% |
| 10 | Xeris Biopharma Holdings | 2.89 Bn | 2.41 Bn | 94.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -4.52% |
| Mar 31, 2025 | -10.71% |
| Dec 31, 2024 | -16.55% |
| Sep 30, 2024 | -21.77% |
| Jun 30, 2024 | -17.23% |
| Mar 31, 2024 | -21.91% |
| Dec 31, 2023 | -22.80% |
| Sep 30, 2023 | -24.38% |
| Jun 30, 2023 | -29.57% |
| Mar 31, 2023 | -29.02% |
| Dec 31, 2022 | -37.92% |
| Sep 30, 2022 | -56.27% |
| Jun 30, 2022 | -53.78% |
| Mar 31, 2022 | -60.91% |
API Access
Xeris Biopharma Holdings Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();